Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer
- PMID: 24771643
- DOI: 10.1158/1078-0432.CCR-13-2952
Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer
Abstract
Purpose: Sirtuins play an important role in cancer development. Sirt7, as a member of this family, is frequently overexpressed in certain carcinomas, but the oncogenic mechanism is seldom reported. In this study, Sirt7 was characterized for its role in colorectal cancer aggressiveness and underlying molecular mechanisms.
Experimental design: Quantitative PCR, Western blotting, and immunohistochemistry were performed to study Sirt7 expression in a cohort of colorectal cancer tissues and non-tumor tissues and cells. A series of in vitro and in vivo assays was performed to elucidate the function of Sirt7 in colorectal cancer and its underlying mechanisms. Association between the Sirt7 signature and survival was examined using Kaplan-Meier analysis and log-rank tests.
Results: The Sirt7 protein level significantly correlated with tumor stage (P = 0.029), lymph node metastasis (P = 0.046), and poor patient survival (P < 0.05). Sirt7 knockdown significantly inhibited colorectal cancer cell proliferation, colony formation, and motility. Ectopic Sirt7 expression promoted colony formation, induced a more invasive phenotype, and accelerated cell growth both in vitro and in vivo. Moreover, Sirt7 enhanced MAPK pathway activity concomitantly with p-ERK and p-MEK upregulation. In Sirt7-overexpressing cells, the mesenchymal markers vimentin and fibronectin were upregulated, and the epithelial markers E-cadherin and β-catenin were downregulated, which was linked to enhanced invasion by colorectal cancer cells.
Conclusion: Our findings suggest that Sirt7 plays an important role in the development and progression of human colorectal cancer and functions as a valuable marker of colorectal cancer prognosis.
©2014 American Association for Cancer Research.
Similar articles
-
Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.Int J Cancer. 2015 Apr 1;136(7):1515-27. doi: 10.1002/ijc.29140. Epub 2014 Sep 3. Int J Cancer. 2015. PMID: 25123959
-
Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.Oncol Rep. 2020 Sep;44(3):959-972. doi: 10.3892/or.2020.7672. Epub 2020 Jul 7. Oncol Rep. 2020. PMID: 32705247 Free PMC article.
-
HOXB7 as a prognostic factor and mediator of colorectal cancer progression.Clin Cancer Res. 2011 Jun 1;17(11):3569-78. doi: 10.1158/1078-0432.CCR-10-2533. Epub 2011 Apr 7. Clin Cancer Res. 2011. PMID: 21474578
-
Sirtuin 7 in cell proliferation, stress and disease: Rise of the Seventh Sirtuin!Cell Signal. 2015 Mar;27(3):673-82. doi: 10.1016/j.cellsig.2014.11.026. Epub 2014 Nov 27. Cell Signal. 2015. PMID: 25435428 Review.
-
[Progress in roles and mechanisms of deacetylase SIRT7].Sheng Wu Gong Cheng Xue Bao. 2019 Jan 25;35(1):13-26. doi: 10.13345/j.cjb.180139. Sheng Wu Gong Cheng Xue Bao. 2019. PMID: 30756531 Review. Chinese.
Cited by
-
The dark side of SIRT7.Mol Cell Biochem. 2024 Nov;479(11):2843-2861. doi: 10.1007/s11010-023-04869-y. Epub 2023 Dec 8. Mol Cell Biochem. 2024. PMID: 38064138 Review.
-
USP39 interacts with SIRT7 to promote cervical squamous cell carcinoma by modulating autophagy and oxidative stress via FOXM1.J Transl Med. 2023 Nov 13;21(1):807. doi: 10.1186/s12967-023-04623-4. J Transl Med. 2023. PMID: 37957720 Free PMC article.
-
SIRT5 Contributes to Colorectal Cancer Growth by Regulating T Cell Activity.J Immunol Res. 2020 Sep 1;2020:3792409. doi: 10.1155/2020/3792409. eCollection 2020. J Immunol Res. 2020. PMID: 32953892 Free PMC article.
-
SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1.Cancer Sci. 2024 Apr;115(4):1209-1223. doi: 10.1111/cas.16091. Epub 2024 Jan 30. Cancer Sci. 2024. PMID: 38288904 Free PMC article.
-
Integrating the Epigenome and Transcriptome of Hepatocellular Carcinoma to Identify Systematic Enhancer Aberrations and Establish an Aberrant Enhancer-Related Prognostic Signature.Front Cell Dev Biol. 2022 Mar 1;10:827657. doi: 10.3389/fcell.2022.827657. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35300417 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous